Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $9.4200 (4.43%) ($9.0200 - $9.5500) on Tue. Jan. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.02% (three month average) | RSI | 70 | Latest Price | $9.4200(4.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 3.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(47%) IWO(43%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -2.51% in a week (0% probabilities). VXX(-13%) VIXM(-8%) UUP(-7%) DIA(-6%) TLT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.51% (StdDev 5.02%) | Hourly BBV | 0 () | Intraday Trend | 4% | | | |
|
5 Day Moving Average | $9.36(0.64%) | 10 Day Moving Average | $9.38(0.43%) | 20 Day Moving Average | $9.01(4.55%) | To recent high | -15.9% | To recent low | 25.4% | Market Cap | $1.379b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |